Safety & Tolerability Study of Chimeric Antigen Receptor T-Reg Cell Therapy in Living Donor Renal Transplant Recipients
ACTIVE_NOT_RECRUITING
Status
Conditions
- Kidney Transplant Rejection
- End Stage Renal Disease
Interventions
Sponsor
Sangamo Therapeutics